TLR4 and chronic kidney disease: In particular, we highlight recent advances in the role of Toll-like receptor 4 (TLR4) and NOD-, LRR- and pyrin-domain-containing protein 3 (NLRP3) inflammasomes in muscle, and we discuss the possible benefits and limitations of targeting the inflammatory response in the treatment of CKD-related PEW.